Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Jun-22 4:31 PM View:  | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 13-Jun-22 | Gift | 400,000 | $0.02 | $6,440.00 | (2%) 23.55M to 23.15M | |
| 13-Jun-22 4:31 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 09-Jun-22 | Sale | 238,164 | $0.02 | $5,001.44 | (1%) 23.8M to 23.56M | |
| 13-Jun-22 4:31 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 08-Jun-22 | Sale | 21,836 | $0.02 | $458.56 | (< 1%) 23.82M to 23.8M | |
| 13-Jun-22 4:31 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 07-Jun-22 | Sale | 50,000 | $0.02 | $1,000.00 | (< 1%) 23.87M to 23.82M | |
| 13-Jun-22 4:31 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 06-Jun-22 | Sale | 10,000 | $0.03 | $250.00 | (< 1%) 23.88M to 23.87M | |
| 02-Jun-22 5:23 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 31-May-22 | Sale | 30,000 | $0.03 | $800.00 | (< 1%) 23.91M to 23.88M | |
| 02-Jun-22 5:23 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 27-May-22 | Sale | 50,000 | $0.03 | $1,450.00 | (< 1%) 23.96M to 23.91M | |
| 02-Jun-22 5:23 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 26-May-22 | Sale | 100,000 | $0.03 | $2,600.00 | (< 1%) 24.06M to 23.96M | |
| 07-Jan-22 5:22 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 07-Jan-22 | Gift | 550,000 | -- | -- | (2%) 24.65M to 24.1M | |
| 07-Jan-22 5:22 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 07-Jan-22 | Sale (Planned) | 41,000 | $0.05 | $1,886.00 | (< 1%) 24.1M to 24.06M | |
| 07-Jan-22 5:22 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 06-Jan-22 | Sale (Planned) | 120,000 | $0.05 | $6,120.00 | (< 1%) 24.77M to 24.65M | |
| 07-Jan-22 5:22 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 05-Jan-22 | Sale (Planned) | 89,000 | $0.05 | $4,183.00 | (< 1%) 24.86M to 24.77M | |
| 02-Aug-21 8:04 AM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 29-Jul-21 | Grant | 1,875,000 | $0.05 | $90,000.00 | 8% 22.98M to 24.86M | |
| 16-Mar-21 4:47 PM View: | Petkanas Dean Chief Executive Officer Director | Neuropathix, Inc. (NPTX) | 12-Mar-21 | Grant | 884,616 | $0.13 | $115,000.00 | 4% 22.71M to 23.59M | |
| 03-Dec-19 3:47 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 27-Nov-19 | Sale | 100,000 | $1.00 | $100,000.00 | (< 1%) 22.19M to 22.09M | |
| 06-May-20 9:38 PM View: | Malasek Robert Director | Neuropathix, Inc. (NPTX) | 14-Aug-19 | Grant | 250,000 | $0.10 | $25,000.00 | 100% 0 to 250.0K | |
| 06-May-20 9:45 PM View: | Scott Timothy Richard Director | Neuropathix, Inc. (NPTX) | 14-Aug-19 | Grant | 250,000 | $0.10 | $25,000.00 | 100% 0 to 250.0K | |
| 06-May-20 9:39 PM View: | Petkanas Dean Chief Executive Officer Director 10% Owner | Neuropathix, Inc. (NPTX) | 14-Aug-19 | Grant Duplicate | 200,000 | $0.10 | $20,000.00 | < 1% 22.09M to 22.29M | |
| 06-May-20 9:36 PM View: | Kinney William Chief Scientific Officer | Neuropathix, Inc. (NPTX) | 14-Aug-19 | Grant | 200,000 | $0.10 | $20,000.00 | 15% 1.33M to 1.53M | |
| 06-May-20 9:39 PM View: | Schroeder Blake Director | Neuropathix, Inc. (NPTX) | 14-Aug-19 | Grant | 250,000 | $0.10 | $25,000.00 | 100% 0 to 250.0K | |
| 08-Aug-18 3:51 PM View: | Kettner Investments, LLC | Neuropathix, Inc. (NPTX) | 25-Jul-18 | Acquisition (other) | 3,067,070 | -- | -- | 41% 7.5M to 10.57M | |
| 08-Aug-18 3:51 PM View: | Kettner Investments, LLC | Neuropathix, Inc. (NPTX) | 25-Jul-18 | Sale | 3,750,000 | -- | -- | (35%) 10.57M to 6.82M |
